Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Concentrix Corp Director's Dealing 2022

Feb 4, 2022

31393_dirs_2022-02-03_3efb5541-d61f-43fc-b43b-7995fc0fa391.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2022-02-01

Reporting Person: POLK DENNIS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-01 Common Stock M 5000 $37.94 Acquired 22532 Direct
2022-02-01 Common Stock S 290 $195.382 Disposed 22242 Direct
2022-02-01 Common Stock S 500 $196.395 Disposed 21742 Direct
2022-02-01 Common Stock S 1400 $198.434 Disposed 20342 Direct
2022-02-01 Common Stock S 1490 $199.385 Disposed 18852 Direct
2022-02-01 Common Stock S 1320 $200.40 Disposed 17532 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-01 Employee Stock Option (Right to Buy) $37.94 M 5000 Disposed 2028-10-11 Common Stock (5000.0) Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.02 to $195.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.20 to $196.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.89 to $198.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.92 to $199.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.07 to $200.99, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: This stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.